Floyd LLeroyCuller IiiMD

Pediatric Endocrinology • Sacramento, CA

Endocrinologist, Center Of Excellence In Diabetes & Endocrinology

Join to view full profile

Are you Dr. Culler Iii?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 21 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
3814 Auburn Blvd
Sacramento, CA 95821
Phone+1 916-426-1902

Fax+1 916-426-1940
Is this information wrong?

Summary

Dr. Floyd L Culler Iii, MD is a pediatric endocrinologist in Sacramento, California. He is currently licensed to practice medicine in California. He is affiliated with Mercy General Hospital and Sutter Medical Center, Sacramento.

Education & Training

University of California (San Diego) Medical CenterFellowship, Pediatric Endocrinology, 1980 - 1983
University of Louisville School of MedicineResidency, Pediatrics, 1978 - 1980
University of Tennessee Health Science Center College of MedicineClass of 1977

Certifications & Licensure

CA State Medical License 1980 - 2024
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Endocrinology

Publications & Presentations

PubMed

Reduced exercise-associated response of the GH-IGF-I axis and catecholamines in obese children and adolescents.
Eliakim, A., Nemet, D., Zaldivar, F., McMurray, R.G., Culler, F.L., Galassetti, P., Cooper, D.M.> ;J Appl Physiol. 2006 May
Severe insulin resistance and diabetes mellitus in mandibuloacral dysplasia.
Freidenberg, G. R., Cutler, D. L., Jones, M. C., Hall, B., Mier, R. J., Culler, F., Jones, K. L., Lozzio, C., Kaufmann, S.> ;Am J Dis Child. 1992 Jan
Angiogenic factor in human ocular fluid.
Baird, A., Culler, F., Jones, K. L., Guillemin, R.> ;Lancet. 1985 Sep 7
Glucocorticoids: potent inhibitors and stimulators of growth hormone secretion.
Wehrenberg, W. B., Janowski, B. A., Piering, A. W., Culler, F., Jones, K. L.> ;Endocrinology. 1990 Jun
The Börjeson-Forssman-Lehmann syndrome.
Robinson, L. K., Jones, K. L., Culler, F., Nyhan, W. L., Sakati, N., Jones, K. L.> ;Am J Med Genet. 1983 Jul
Preservation of growth hormone secretion in response to growth hormone-releasing peptide-2 during prednisone therapy.
Meacham, L. R., Culler, F. L., Abdul-Latif, H., Sullivan, K. M., Bowers, C. Y.> ;Metabolism. 1999 May
Predictors of change in insulin sensitivity during glucocorticoid treatment.
Meacham, L. R., Abdul-Latif, H., Sullivan, K., Culler, F. L.> ;Horm Metab Res. 1997 Apr
Decreased reverse T3 levels in neonates with central hypothyroidism.
Faase, E. M., Meacham, L. R., Novack, C. M., Brakin, M. I., Mosier, H. D., Culler, F. L.> ;J Perinatol. 1997 Jan 01
Growth promoting peptides in diabetic and non-diabetic pregnancy: interactions with trophoblastic receptors and serum carrier proteins.
Culler, F. L., Tung, R. F., Jansons, R. A., Mosier, H. D.> ;J Pediatr Endocrinol Metab. 1996 Jan 01
Preservation of somatostatin secretion in cystic fibrosis patients with diabetes.
Meacham, L. R., Caplan, D. B., McKean, L. P., Buchanan, C. N., Parks, J. S., Culler, F. L.> ;Arch Dis Child. 1993 Jan
Glipizide treatment of patients with cystic fibrosis and impaired glucose tolerance.
Culler, F. L., McKean, L. P., Buchanan, C. N., Caplan, D. B., Meacham, L. R.> ;J Pediatr Gastroenterol Nutr. 1994 Apr
Effect of hypersomatostatinemia on growth hormone secretion in cystic fibrosis patients with diabetes.
Culler, F. L., Meacham, L. R.> ;Neuroendocrinology. 1993 Oct
Hypopituitarism in association with postaxial polydactyly.
Culler, F. L., Jones, K. L.> ;J Pediatr. 1984 Jun
The cytoreceptor assay for 1,25-dihydroxyvitamin D and its application to clinical studies.
Manolagas, S. C., Culler, F. L., Howard, J. E., Brickman, A. S., Deftos, L. J.> ;J Clin Endocrinol Metab. 1983 Apr
Imparied calcitonin secretion in patients with Williams syndrome.
Culler, F. L., Jones, K. L., Deftos, L. J.> ;J Pediatr. 1985 Nov 01
Identification of gonadotropin-releasing hormone in neurons of a hypothalamic hamartoma in a boy with precocious puberty.
Culler, F. L., James, H. E., Simon, M. L., Jones, K. L.> ;Neurosurgery. 1985 Sep 01
Immunospecific therapy for type I diabetes mellitus.
Culler, F. L., O'Connor, R., Kaufmann, S., Jones, K. L., Roth, J. C.> ;N Engl J Med. 1985 Sep 12
Traumatic hypopituitarism due to a gunshot wound.
Trujillo-Juarez, D., Culler, F. L., Ganelin, R. S., Jones, K. L.> ;West J Med. 1987 Nov
Calcitropic hormones in childhood.
Culler, F. L.> ;Pediatr Ann. 1987 Dec
Comparison of the acute metabolic effects of 22,000-dalton and 20,000-dalton growth hormone in human subjects.
Culler, F. L., Kaufmann, S., Frigeri, L. G., Jones, K. L.> ;Horm Metab Res. 1988 Feb
Inhibition by prednisone of growth hormone (GH) response to GH-releasing hormone in normal men.
Kaufmann, S., Jones, K. L., Wehrenberg, W. B., Culler, F. L.> ;J Clin Endocrinol Metab. 1988 Dec
Growth hormone deficiency in the Rothmund-Thomson syndrome.
Kaufmann, S., Jones, M., Culler, F. L., Jones, K. L.> ;Am J Med Genet. 1986 Apr
Release of the 22,000- and the 20,000-dalton variants of growth hormone in vivo and in vitro by human anterior pituitary cells.
Markoff, E., Lee, D. W., Culler, F. L., Jones, K. L., Lewis, U. J.> ;J Clin Endocrinol Metab. 1986 Apr
An in vivo model for study of the angiogenic effects of basic fibroblast growth factor.
Hayek, A., Culler, F. L., Beattie, G. M., Lopez, A. D., Cuevas, P., Baird, A.> ;Biochem Biophys Res Commun. 1987 Sep 15
Double vagina, cardiac, pulmonary, and other genital malformations with 46,XY karyotype.
Meacham, L. R., Winn, K. J., Culler, F. L., Parks, J. S.> ;Am J Med Genet. 1991 Dec 15
Join now to see all

Grant Support

Case Management Approach For The Treatment Of Childhood Obesity-Feasibility AnNational Center For Research Resources2006

Hospital Affiliations

Mercy General HospitalSacramento, California
Sutter Medical Center, SacramentoSacramento, California